Journal
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
Volume 26, Issue 12, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejoc.202300052
Keywords
CSF1R inhibitor; Fluorination; Negishi cross-coupling; synthetic methods; pyrrolopyrimidine
Categories
Ask authors/readers for more resources
The colony-stimulating factor 1 receptor (CSF1R) is identified as a potential therapeutic target in cancer, CNS, and inflammatory diseases. Molecular docking and synthesis studies have led to the discovery of low molecular weight compounds that show promise as lead candidates for optimization. These compounds are synthesized from a 4-chloro-6-iodo-pyrrolo[2,3-d]pyrimidine building block using Negishi and Suzuki-Miyaura cross-coupling reactions with high yields. Several inhibitors exhibit excellent enzymatic potency, with the parent compound preferentially binding to the autoinhibited form of CSF1R. Cellular and in vivo profiling suggest further structural tuning is required before efficacy studies.
The colony-stimulating factor 1 receptor (CSF1R) is a protein kinase emerging as an attractive target with clinical relevance in cancer, CNS and inflammatory diseases. Molecular docking experiments followed by synthesis and structure-activity relationship have been used to identify low molecular weight structures as promising hits for lead optimization. These molecules are synthesized from a 4-chloro-6-iodo-pyrrolo[2,3-d]pyrimidine building block using Negishi and Suzuki-Miyaura cross-coupling reactions in high yields. Several inhibitors possessed excellent enzymatic potency, and the parent compound preferably binds to the autoinhibited form of CSF1R. Cellular and in vivo profiling indicate that further tuning of drug structure is needed prior to efficacy studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available